BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zare-Bidaki M, Tsukiyama-Kohara K, Arababadi MK. Toll-like receptor 4 and hepatitis B infection: molecular mechanisms and pathogenesis. Viral Immunol. 2014;27:321-326. [PMID: 25014492 DOI: 10.1089/vim.2014.0039] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Xu CL, Hao YH, Lu YP, Tang ZS, Yang XC, Wu J, Zheng X, Wang BJ, Liu J, Yang DL. Upregulation of toll-like receptor 4 on T cells in PBMCs is associated with disease aggravation of HBV-related acute-on-chronic liver failure. J Huazhong Univ Sci Technolog Med Sci 2015;35:910-5. [PMID: 26670445 DOI: 10.1007/s11596-015-1527-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
2 Alvarez Rojas CA, Ansell BR, Hall RS, Gasser RB, Young ND, Jex AR, Scheerlinck JP. Transcriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver. Parasit Vectors 2015;8:124. [PMID: 25885344 DOI: 10.1186/s13071-015-0715-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
3 Das D, Sarkar N, Sengupta I, Pal A, Saha D, Bandopadhyay M, Das C, Narayan J, Singh SP, Chakravarty R. Anti-viral role of toll like receptor 4 in hepatitis B virus infection: An in vitro study. World J Gastroenterol 2016; 22(47): 10341-10352 [PMID: 28058014 DOI: 10.3748/wjg.v22.i47.10341] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nasiri E, Kariminik A. Up-regulation of AIM2 and TLR4 and down-regulation of NLRC4 are associated with septicemia. Indian J Med Microbiol 2021;39:334-8. [PMID: 34099337 DOI: 10.1016/j.ijmmb.2021.05.002] [Reference Citation Analysis]
5 Asadzadeh Manjili F, Yousefi-Ahmadipour A, Kazemi Arababadi M. The roles played by TLR4 in the pathogenesis of multiple sclerosis; A systematic review article. Immunol Lett 2020;220:63-70. [PMID: 32032617 DOI: 10.1016/j.imlet.2020.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Li J, Hu L, Liu Y, Huang L, Mu Y, Cai X, Weng C. DDX19A Senses Viral RNA and Mediates NLRP3-Dependent Inflammasome Activation. J I 2015;195:5732-49. [DOI: 10.4049/jimmunol.1501606] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
7 Wu T, Li F, Chen Y, Wei H, Tian Z, Sun C, Sun R. CD4+ T Cells Play a Critical Role in Microbiota-Maintained Anti-HBV Immunity in a Mouse Model. Front Immunol. 2019;10:927. [PMID: 31114580 DOI: 10.3389/fimmu.2019.00927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Dadmanesh M, Ranjbar MM, Ghorban K. Inflammasomes and their roles in the pathogenesis of viral hepatitis and their related complications: An updated systematic review. Immunol Lett 2019;208:11-8. [PMID: 30831142 DOI: 10.1016/j.imlet.2019.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mohamadkhani A, Bastani F, Khorrami S, Ghanbari R, Eghtesad S, Sharafkhah M, Montazeri G, Poustchi H. Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B Infection. Hepat Mon. 2015;15:e28315. [PMID: 26288634 DOI: 10.5812/hepatmon.28315v2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
10 Arababadi MK, Nosratabadi R, Asadikaram G. Vitamin D and toll like receptors. Life Sci 2018;203:105-11. [PMID: 29596922 DOI: 10.1016/j.lfs.2018.03.040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
11 Zhang R, Real CI, Liu C, Baba HA, Gerken G, Lu M, Broering R. Hepatic expression of oncogenes Bmi1 and Dkk1 is up-regulated in hepatitis B virus surface antigen-transgenic mice and can be induced by treatment with HBV particles or lipopolysaccharides in vitro. Int J Cancer 2017;141:354-63. [PMID: 28419472 DOI: 10.1002/ijc.30742] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
12 Sepehri Z, Kiani Z, Kohan F, Ghavami S. Toll-Like Receptor 4 as an Immune Receptor Against Mycobacterium tuberculosis: A Systematic Review. Lab Med 2019;50:117-29. [PMID: 30124945 DOI: 10.1093/labmed/lmy047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
13 Sepehri Z, Kiani Z, Kohan F, Alavian SM, Ghavami S. Toll like receptor 4 and hepatocellular carcinoma; A systematic review. Life Sci 2017;179:80-7. [PMID: 28472619 DOI: 10.1016/j.lfs.2017.04.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
14 Tao X, Wang N, Qin W. Gut Microbiota and Hepatocellular Carcinoma. Gastrointest Tumors. 2015;2:33-40. [PMID: 26673641 DOI: 10.1159/000380895] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
15 Zhang SH, Yu MJ, Yan JL, Xiao JH, Xiao Y, Yang JL, Lei J, Yu X, Chen WL, Chai Y. TLR4 Knockout Attenuates BDL-induced Liver Cholestatic Injury through Amino Acid and Choline Metabolic Pathways. Curr Med Sci 2021;41:572-80. [PMID: 34047945 DOI: 10.1007/s11596-021-2364-8] [Reference Citation Analysis]
16 Khademalhosseini M, Arababadi MK. Toll-like receptor 4 and breast cancer: an updated systematic review. Breast Cancer 2019;26:265-71. [PMID: 30543015 DOI: 10.1007/s12282-018-00935-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Nosratababadi R, Bagheri V, Zare-Bidaki M, Hakimi H, Zainodini N, Kazemi Arababadi M. Toll like receptor 4: an important molecule in recognition and induction of appropriate immune responses against Chlamydia infection. Comp Immunol Microbiol Infect Dis 2017;51:27-33. [PMID: 28504091 DOI: 10.1016/j.cimid.2017.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
18 Safaei S, Karimi-Googheri M. Letter to the Editor: Toll-Like Receptor Antagonists as a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients. Viral Immunol 2021;34:361-2. [PMID: 33012270 DOI: 10.1089/vim.2020.0074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Afsharimoghaddam A, Soleimani M, Lashay A, Dehghani M, Sepehri Z. Controversial roles played by toll like receptor 4 in urinary bladder cancer; A systematic review. Life Sci 2016;158:31-6. [PMID: 27316642 DOI: 10.1016/j.lfs.2016.06.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
20 Bakhshi Aliabad MH, Jafari E, Karimi Kakh M, Nosratababadi R, Bakhshi H, Sheikhha MH, Bidaki R, Askari A, Kazemi Arababadi M. Anxiety leads to up-regulation of CD36 on the monocytes of chronic hepatitis B-infected patients. Int J Psychiatry Med 2016;51:467-75. [PMID: 28629284 DOI: 10.1177/0091217416680199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Hansson E, Skiöldebrand E. Coupled cell networks are target cells of inflammation, which can spread between different body organs and develop into systemic chronic inflammation. J Inflamm (Lond) 2015;12:44. [PMID: 26213498 DOI: 10.1186/s12950-015-0091-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
22 Golshiri-Isfahani A, Amizadeh M, Arababadi MK. The roles of toll like receptor 3, 7 and 8 in allergic rhinitis pathogenesis. Allergol Immunopathol (Madr) 2018;46:503-7. [PMID: 29398117 DOI: 10.1016/j.aller.2017.09.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
23 Naghib M, Kariminik A, Kazemi Arababadi M. TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome. Viral Immunol 2022. [PMID: 35020525 DOI: 10.1089/vim.2021.0141] [Reference Citation Analysis]
24 Pandey N, Chauhan A, Jain N. TLR4 Polymorphisms and Expression in Solid Cancers. Mol Diagn Ther 2018;22:683-702. [PMID: 30311146 DOI: 10.1007/s40291-018-0361-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
25 Bahramabadi R, Dabiri S, Iranpour M, Kazemi Arababadi M. TLR4: An Important Molecule Participating in Either Anti-Human Papillomavirus Immune Responses or Development of Its Related Cancers. Viral Immunol 2019;32:417-23. [PMID: 31721657 DOI: 10.1089/vim.2019.0061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Yuan G, Chen B, Meng Y, Lu J, Shi X, Hu A, Hu Y, Wang D. Role of the CXCR3‑mediated TLRs/MyD88 signaling pathway in promoting the development of hepatitis B into cirrhosis and liver cancer. Mol Med Rep 2021;24:738. [PMID: 34435646 DOI: 10.3892/mmr.2021.12378] [Reference Citation Analysis]
27 Yousefi-ahmadipour A, Sartipi M, Khodadadi H, Shariati-kohbanani M, Arababadi MK. Toll-like receptor 4 and the inflammation during aging. JGG 2022. [DOI: 10.36150/2499-6564-n471] [Reference Citation Analysis]
28 Wang G, Wang H, Singh S, Zhou P, Yang S, Wang Y, Zhu Z, Zhang J, Chen A, Billiar T, Monga SP, Wang Q. ADAR1 Prevents Liver Injury from Inflammation and Suppresses Interferon Production in Hepatocytes. Am J Pathol 2015;185:3224-37. [PMID: 26453800 DOI: 10.1016/j.ajpath.2015.08.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
29 Hakimizadeh E, Shamsizadeh A, Roohbakhsh A, Arababadi MK, Hajizadeh MR, Shariati M, Fatemi I, Moghadam-Ahmadi A, Bazmandegan G, Rezazadeh H, Allahtavakoli M. TRPV1 receptor-mediated expression of Toll-like receptors 2 and 4 following permanent middle cerebral artery occlusion in rats. Iran J Basic Med Sci 2017;20:863-9. [PMID: 29085577 DOI: 10.22038/IJBMS.2017.9107] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
30 Gao S, Chen T, Li L, Liu X, Liu Y, Zhao J, Lu Q, Zeng Z, Xu Q, Huang D, Tu K. Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma. Front Cell Dev Biol 2020;8:587389. [PMID: 33195243 DOI: 10.3389/fcell.2020.587389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]